CLEMENT PHARMA
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
14-08
full format · 14 days late
2025
31-12
Financial
Weakest financial yearnet -€160,504
The net result drops to -€160,504, the lowest from 2018 to 2025.
15-09
Gazette deed
3 directors appointed, 1 reappointedReappointment: 4CC BV (director) · Permanent representatives: Vandecappelle Els and Clement Jan · Appointments: 4 GC SARL (director) and 4CC BV (managing director)8 points ▸
Gazette deed
3 directors appointed, 1 reappointed
Reappointment: 4CC BV (director) · Permanent representatives: Vandecappelle Els and Clement Jan · Appointments: 4 GC SARL (director) and 4CC BV (managing director)8 points ▸
- General meeting, 28-06-2025
- Director reappointment, 4CC BV (director)
- Permanent representative, Vandecappelle Els
- Director appointment, 4 GC SARL (director)
- Permanent representative, Clement Jan
- Board meeting, 28-06-2025
- Director appointment, 4CC BV (managing director)
- Director appointment, 4 GC SARL (managing director)
- The act holds 1 more point.
16-07
abbreviated format · 15 days before the deadline
2024
31-12
Financial
Back to profitnet €47,328
The net result is €47,328, after one loss-making year.
31-12
Financial
Equity above €1mequity €1.0m ▲4.9%
Equity rises from €973,763 to €1.0m.
24-07
abbreviated format · 7 days before the deadline
2023
05-10
Gazette deed
2 directors resigning, 1 reappointedResignations: Denise BOUCKAERT (director) and Els VANDECAPPELLE (bestuurder,gedelegeerd bestuurder en voorzitter) · Permanent representative: Els VANDECAPPELLE · Reappointment: Els VANDECAPPELLE (sole director)8 points ▸
Gazette deed
2 directors resigning, 1 reappointed
Resignations: Denise BOUCKAERT (director) and Els VANDECAPPELLE (bestuurder,gedelegeerd bestuurder en voorzitter) · Permanent representative: Els VANDECAPPELLE · Reappointment: Els VANDECAPPELLE (sole director)8 points ▸
- General meeting, 18-09-2023
- Purpose change, “nieuwe tekst van statuten” (deed in Dutch)
- Director resignation, Denise BOUCKAERT (director)
- Director resignation, Els VANDECAPPELLE (bestuurder,gedelegeerd bestuurder en voorzitter)
- Permanent representative, Els VANDECAPPELLE, mentioned 2 times in the deed
- Director reappointment, Els VANDECAPPELLE (sole director)
- Capital, €62,000, 1,500 shares
- Power of attorney, Andreas LAGA
- The act holds 7 more points.
30-05
abbreviated format · 62 days before the deadline
2022
31-12
Financial
Back to profitnet €272,214
The net result is €272,214, after one loss-making year.
27-06
abbreviated format · 34 days before the deadline
2021
23-07
abbreviated format · 8 days before the deadline
Show earlier events
2020
24-06
abbreviated format · 37 days before the deadline
2019
31-12
Financial
Back to profitnet €189,921
The net result is €189,921, after one loss-making year.
16-07
abbreviated format · 15 days before the deadline
2018
20-07
abbreviated format · 11 days before the deadline
2017
26-06
abbreviated format · 35 days before the deadline
1983
01-01
Gazette deed
Incorporation
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank